Management of refractory generalized myasthenia gravis with eculizumab during pregnancy and puerperium: a case report
Myasthenia gravis (MG) mostly affects women of childbearing age. Since the disease course may be affected during pregnancy and postpartum, monitoring and appropriate treatment of MG in pregnant women are crucial. Current treatment options for pregnant women with refractory MG are limited by possible...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioExcel Publishing Ltd
2025-10-01
|
| Серии: | Drugs in Context |
| Предметы: | |
| Online-ссылка: | https://www.drugsincontext.com/management-of-refractory-generalized-myasthenia-gravis-with-eculizumab-during-pregnancy-and-puerperium-a-case-report/ |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
